| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Conversion | Series B Preferred Stock | 658k | $0.00 | $0 | See footnote | 07/06/2021 |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Conversion | Series B Preferred Stock | 1.3M | $0.00 | $0 | See footnote | 07/06/2021 |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Conversion | Series A-1 Preferred Stock | 1.6M | $0.00 | $0 | See footnote | 07/06/2021 |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Conversion | Common Stock | 658k | $0.00 | $0 | See footnote | 07/06/2021 |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Purchase | Common Stock | 312.5k | $16.00 | $5M | See footnote | 07/06/2021 |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Conversion | Common Stock | 3M | $0.00 | $0 | See footnote | 07/06/2021 |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Conversion | Series B Preferred Stock | 2.1M | $0.00 | $0 | See footnote | 07/06/2021 |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Conversion | Series A-1 Preferred Stock | 1.1M | $0.00 | $0 | See footnote | 07/06/2021 |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Purchase | Common Stock | 750k | $16.00 | $12M | See footnote | 07/06/2021 |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Conversion | Common Stock | 2.1M | $0.00 | $0 | See footnotes | 07/06/2021 |
| 07/06/2021 | Acumen Pharmaceuticals, Inc. | | Conversion | Common Stock | 1.1M | $0.00 | $0 | See footnote | 07/06/2021 |